Bharat Edition

Bharatstox

← All stocks

Divi's Laboratories Ltd.

NSE: DIVISLAB · Healthcare

Sector

Healthcare

Size band

Large cap

Market cap

1,55,282cr

P/E

61.7

ROE

15.6%

Dividend yield

0.5%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin41.0%
peer 20.5%
Revenue growth27.8%
peer 16.1%
Divi's Laboratories Ltd.peer median

Peer set

Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
Sun Pharmaceutical Industries Ltd.29.0%10.5%
Divi's Laboratories Ltd.41.0%27.8%
Torrent Pharmaceuticals Ltd.34.0%54.8%
Lupin Ltd.30.0%32.1%
Dr. Reddy's Laboratories Ltd.11.0%−5.5%
Cipla Ltd.17.0%2.3%
Zydus Lifesciences Ltd.24.0%22.0%
Mankind Pharma Ltd.26.0%12.9%
Aurobindo Pharma Ltd.21.0%16.3%
Torrent Power Ltd.19.0%2.8%
Alkem Laboratories Ltd.20.0%10.9%
Glenmark Pharmaceuticals Ltd.20.0%23.1%

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Divi's Laboratories Ltd..

On air

20 calls · outcomes not tracked

Recorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.

Channel & showAiredStated targetStated stopOutcome
Zee BusinessZee Business · no registration attached28 Aug+1.0%-0.7%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug-6.8%still open
CNBC AwaazCNBC Awaax · no registration attached27 Aug-6.8%still open
CNBC AwaazCNBC Awaax · no registration attached26 Aug-6.9%still open
CNBC AwaazCNBC Awaax · no registration attached25 Aug+0.8%-0.5%still open
CNBC AwaazCNBC Awaax · no registration attached25 Aug+0.7%-0.5%still open
CNBC AwaazCNBC Awaax · no registration attached25 Aug+0.6%-0.3%still open
CNBC AwaazCNBC Awaax · no registration attached25 Aug+0.5%-0.4%still open
NDTV ProfitNDTV Profit · no registration attached19 Aug+3.3%-2.3%still open
NDTV ProfitNDTV Profit · no registration attached12 Aug+8.5%-4.7%still open
NDTV ProfitNDTV Profit · no registration attached12 Aug+8.5%-4.7%still open
NDTV ProfitNDTV Profit · no registration attached12 Aug+8.6%-4.6%still open
NDTV ProfitNDTV Profit · no registration attached12 Aug+8.4%-4.8%still open
NDTV ProfitNDTV Profit · no registration attached12 Aug+8.4%-4.8%still open
NDTV ProfitNDTV Profit · no registration attached12 Aug+7.8%-5.3%still open
NDTV ProfitNDTV Profit · no registration attached12 Aug+8.8%-4.4%still open
Zee BusinessZee Business · no registration attached11 Aug+2.9%-3.1%still open
Zee BusinessZee Business · no registration attached11 Aug+2.9%-3.1%still open
Zee BusinessZee Business · no registration attached11 Aug+2.4%-3.1%still open
Zee BusinessZee Business · no registration attached11 Aug+3.0%-3.1%still open

Shareholding

change across 4 filings
CategoryJun 26Mar 26Dec 25Sep 25Change
Promoters51.951.951.951.90.0
Foreign institutions20.220.320.119.4+0.8
Domestic institutions19.419.219.319.8−0.4
Retail & others8.58.68.89.0−0.5

As filed with the exchange for the periods ending Sep 25 to Jun 26.

Filings

latest 25 of 107
  • Shareholders meeting10 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates6 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication3 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Retirement31 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates24 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication17 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting15 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication13 Jul 2026
    Medium impactDividendFiling PDF ↗
  • Certificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Disclosure under SEBI Takeover Regulations6 Jul 2026
    High impactM&AFiling PDF ↗
  • Trading Window30 Jun 2026
    Medium impactInsider TradingFiling PDF ↗
  • Updates11 Jun 2026
    Medium impactDividendFiling PDF ↗
  • Copy of Newspaper Publication4 Jun 2026
    Medium impactDividendFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates29 May 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication25 May 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of Board Meeting25 May 2026
    RoutineBoard MeetingFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates15 May 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication15 May 2026
    RoutineGeneralFiling PDF ↗
  • Certificate under SEBI (Depositories and Participants) Regulations, 20186 Apr 2026
    RoutineGeneralFiling PDF ↗
  • Trading Window31 Mar 2026
    Medium impactInsider TradingFiling PDF ↗
  • Copy of Newspaper Publication12 Feb 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates11 Feb 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of Board Meeting11 Feb 2026
    RoutineBoard MeetingFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates3 Feb 2026
    RoutineGeneralFiling PDF ↗
  • Trading Window31 Dec 2025
    Medium impactInsider TradingFiling PDF ↗

The 25 most recent of 107 filings we hold for DIVISLAB, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.